SNOA Historical Earnings image   This SNOA historical earnings page last updated 2/14/2022
SNOA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 20222/11/20220.00B
Q2 202211/15/20210.00B
Q1 20228/16/20210.00B
Q4 20217/14/20210.00B
Q3 20212/16/20210.00B
Q2 202111/20/20200.01B
Q1 20218/14/20200.01B
Q4 20207/10/20200.00B
Q3 20202/14/20200.00B
Q2 202011/14/20190.00B
Q1 20208/13/20190.00B
Q4 20197/8/20190.00B
Q3 20192/14/20195.28M
Q2 201911/8/20184.94M
Q1 20198/8/20184.37M
Q4 20186/13/20183.65M
Q3 20182/7/20184.84M
Q2 201811/9/20174.33M
Q1 20188/9/20173.83M
Q4 20176/5/20174.03M
Q3 20172/9/20173.36M
Q2 201711/10/20164.11M
Q1 20177/28/20163.81M
Q4 20166/16/20163.53M
Q3 20162/4/20163.82M
Q2 201611/5/20154.05M
Q1 20167/30/20153.68M
Q4 20156/11/20153.98M
Q3 20152/12/20153.22M
Q2 201511/12/20143.26M
Q1 20158/7/20143.40M
Q4 20146/12/20142.91M
Q3 20142/13/20143.29M
Q2 201411/19/20134.09M
Q1 20148/8/20133.40M
Q4 20136/13/20133.30M
SNOA Historical Earnings EPS
Data adjusted for SNOA split history

PeriodHistorical Earnings DateGAAP
Q3 20222/11/2022-0.310
Q2 202211/15/2021-0.040
Q1 20228/16/2021-0.520
Q4 20217/14/2021-1.640
Q3 20212/16/2021-0.310
Q2 202111/20/20200.080
Q1 20218/14/20200.020
Q4 20207/10/2020-0.770
Q3 20202/14/2020-0.720
Q2 202011/14/2019-0.910
Q1 20208/13/2019-1.320
Q4 20197/8/2019-2.450
Q3 20192/14/2019-2.34
Q2 201911/8/2018-3.96
Q1 20198/8/2018-4.95
Q4 20186/13/2018-8.37
Q3 20182/7/2018-6.57
Q2 201811/9/2017-6.03
Q1 20188/9/2017-7.38
Q4 20176/5/2017-6.21
Q3 20172/9/20171.62
Q2 201711/10/2016-4.14
Q1 20177/28/2016-4.50
Q4 20166/16/2016-1.26
Q3 20162/4/2016-1.35
Q2 201611/5/2015-0.99
Q1 20167/30/2015-1.35
Q4 20156/11/2015-0.99
Q3 20152/12/2015-1.35
Q2 201511/12/2014-0.72
Q1 20158/7/2014-0.09
Q4 20146/12/20148.91
Q3 20142/13/2014-0.81
Q2 201411/19/2013-1.89
Q1 20148/8/2013-2.34
Q4 20136/13/2013-3.96
Quotes delayed 20 minutes

Email EnvelopeFree SNOA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sonoma Pharmaceuticals (SNOA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SNSE Past Earnings
SOLY Past Earnings
SONN Past Earnings
SPNE Past Earnings
SPPI Past Earnings
SPRB Past Earnings
SPRO Past Earnings
SQZ Past Earnings
SRDX Past Earnings
SRGA Past Earnings
What was the record high SNOA historical earnings result?
In terms of earnings or revenue, what is the best SNOA historical earnings result that Sonoma Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SNOA historical earnings result was set in Q4 2014, when Sonoma Pharmaceuticals posted results of 8.91/share. The most successful revenue quarter within our data set was Q1 2021 when Sonoma Pharmaceuticals reported revenue of 0.01B.

What was the lowest Sonoma Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SNOA has reported, and when?

✔️Accepted answer: Within our data set, the lowest SNOA historical earnings result was set in Q4 2018, when Sonoma Pharmaceuticals posted results of -8.37/share. The smallest revenue quarter within our data set was Q4 2021 when Sonoma Pharmaceuticals reported revenue of 0.00B.

On this page we presented the SNOA historical earnings date information for Sonoma Pharmaceuticals. Reviewing that SNOA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2014, when SNOA posted gaap of 8.91/share. Meanwhile the lowest SNOA historical earnings result was in Q4 2018, when SNOA posted gaap of -8.37/share. Moving to Sonoma Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2021 when SNOA reported 0.01B in revenue, while the smallest revenue quarter was Q4 2021 when SNOA reported 0.00B in revenue.

For self directed investors doing their due diligence on SNOA or any other given stock, their research can benefit from looking into all of the Sonoma Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Sonoma Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SNOA. Thanks for visiting, and the next time you need to research SNOA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ME Videos, Institutional Holders of MET, GDOT Historical Stock Prices.

 

SNOA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.